Skip to main content

View all Gertz J publications in the NIH PubMed database

Selected Publications

Estrogen Receptor Alpha Mutations in Breast Cancer Cells Cause Gene Expression Changes through Constant Activity and Secondary Effects.
Arnesen S, Blanchard Z, Williams MM, Berrett KC, Li Z, Oesterreich S, Richer JK, Gertz J.Cancer Res. 2021 Feb 1;81(3):539-551. doi: 10.1158/0008-5472.CAN-20-1171. Epub 2020 Nov 12.


Regulatory sharing between estrogen receptor α bound enhancers.
Carleton JB, Ginley-Hidinger M, Berrett KC, Layer RM, Quinlan AR, Gertz J. Nucleic Acids Res. 2020 Jul 9;48(12):6597-6610. doi: 10.1093/nar/gkaa454.


ETV4 Is Necessary for Estrogen Signaling and Growth in Endometrial Cancer Cells.
Rodriguez AC, Vahrenkamp JM, Berrett KC, Clark KA, Guillen KP, Scherer SD, Yang CH, Welm BE, Janát-Amsbury MM, Graves BJ, Gertz J.Cancer Res. 2020 Mar 15;80(6):1234-1245. doi: 10.1158/0008-5472.CAN-19-1382. Epub 2020 Feb 11.


FFPEcap-seq: a method for sequencing capped RNAs in formalin-fixed paraffin-embedded samples.
Vahrenkamp JM, Szczotka K, Dodson MK, Jarboe EA, Soisson AP, Gertz J. Genome Res. 2019 Nov;29(11):1826-1835. doi: 10.1101/gr.249656.119. Epub 2019 Oct 24.


Sufficiency analysis of estrogen responsive enhancers using synthetic activators.
Ginley-Hidinger M, Carleton JB, Rodriguez AC, Berrett KC, Gertz J. Life Sci Alliance. 2019 Sep 30;2(5):e201900497. doi: 10.26508/lsa.201900497. Print 2019 Oct.


Estrogen-independent molecular actions of mutant estrogen receptor 1 in endometrial cancer.
Blanchard Z, Vahrenkamp JM, Berrett KC, Arnesen S, Gertz J. Genome Res. 2019 Sep;29(9):1429-1441. doi: 10.1101/gr.244780.118. Epub 2019 Jul 30.


Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions.
Rodriguez AC, Blanchard Z, Maurer KA, Gertz J.
Horm Cancer. 2019 Jun;10(2-3):51-63. doi: 10.1007/s12672-019-0358-9. Epub 2019 Feb 2.


Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer.
Vahrenkamp JM, Yang CH, Rodriguez AC, Almomen A, Berrett K, Trujillo AN, Guillen KP, Welm BE, Jarboe
EA, Janat-Amsbury MM, Gertz J (2018). Cell Reports. 22(11), 2995-3005.


Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor alpha-Bound Enhancers.
Carleton JB, Berrett KC, Gertz J (2017).
LID - S2405-4712(17)30383-6 [pii]LID -10.1016/j.cels.2017.08.011 [doi]. (Epub ahead of print) Cell Systems.


Distinct properties of cell-type-specific and shared transcription factor binding sites.
Gertz J, Savic D, Varley KE, Partridge EC, Safi A, Jain P, Cooper GM, Reddy TE, Crawford GE, Myers RM(2013).
Mol Cell, 52(1), 25-36.


Analysis of combinatorial cis-regulation in synthetic and genomic promoters.
Gertz J, Siggia ED, Cohen BA (2009).
Nature, 457(7226), 215-8.